CASIRIVIMAB AND IMDEVIMAB (Ronapreve®)

Clinical Indication

For patients hospitalised due to COVID-19

Date of classification

October 2021

Review date

October 2021

Red

Drugs which should be prescribed only by hospital specialists (clinical review by specialist as appropriate and annually as a minimum).